# Infiltration Analgesia After Caesarean Section

> **NCT01094106** · PHASE4 · COMPLETED · sponsor: **North Karelia Central Hospital** · enrollment: 70 (actual)

## Conditions studied

- Pain, Postoperative
- Caesarean Section

## Interventions

- **DRUG:** Ropivacaine 0,75%
- **DRUG:** NaCl 0,9%

## Key facts

- **NCT ID:** NCT01094106
- **Lead sponsor:** North Karelia Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2020-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01094106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01094106, "Infiltration Analgesia After Caesarean Section". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01094106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*